Vaibhav Soni, Suryapriya B., Khushi Rode, Priti Paul, Rahul Nair, Bharath M et al. HER2 as a therapeutic target for CAR T-cell therapy: biological basis, clinical progress, challenges, and future perspectives. // International Journal of Pharmaceutics. – 2027. – DOI: 10.1016/j.ijpharm.2026.127690. – URL: https://doi.org/10.1016/j.ijpharm.2026.127690
Vaibhav Soni, Suryapriya B, Khushi Rode, Priti Paul, Rahul Nair, Bharath M, Anish Dhuri, Tanmoy Kanp, Anamika Sharma, & Pankaj Kumar Singh (2027). HER2 as a therapeutic target for CAR T-cell therapy: biological basis, clinical progress, challenges, and future perspectives. International Journal of Pharmaceutics. https://doi.org/10.1016/j.ijpharm.2026.127690
Vaibhav Soni, et al. “HER2 as a therapeutic target for CAR T-cell therapy: biological basis, clinical progress, challenges, and future perspectives.” International Journal of Pharmaceutics, 2027. doi:10.1016/j.ijpharm.2026.127690.
@article{Soni2027,
title = {HER2 as a therapeutic target for CAR T-cell therapy: biological basis, clinical progress, challenges, and future perspectives},
author = {Soni, Vaibhav and B., Suryapriya and Rode, Khushi and Paul, Priti and Nair, Rahul and M, Bharath and Dhuri, Anish and Kanp, Tanmoy and Sharma, Anamika and Singh, Pankaj Kumar},
journal = {International Journal of Pharmaceutics},
year = {2027},
doi = {10.1016/j.ijpharm.2026.127690},
url = {https://doi.org/10.1016/j.ijpharm.2026.127690}
}